Result
The result fell in 2025 from €88,034 to €36,092.
In July 2024, 39,274 companies had the same profile as ISCARE has now. Each dot stands for 99 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for ISCARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
ISCARE files the micro format. That format states no turnover. The gross margin fell from €97,071 in 2023 to €42,182 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €170,000. Estimated: probably between €100,000 and €310,000.
| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
247,026 | 200,010 | 103,068 | |
21/28 |
2,040 | 2,713 | 4,380 | |
22/27 |
2,040 | 2,713 | 4,380 | |
24 |
2,040 | 2,713 | 4,380 | |
29/58 |
244,986 | 197,297 | 98,689 | |
40/41 |
134,433 | 99,946 | 61,470 | |
40 |
- | - | 268 | |
41 |
134,433 | 99,946 | 61,201 | |
54/58 |
100,903 | 84,350 | 22,449 | |
490/1 |
9,650 | 13,000 | 14,770 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
247,026 | 200,010 | 103,068 | |
10/15 |
199,419 | 163,326 | 75,292 | |
10/11 |
5,000 | 5,000 | 5,000 | |
13 |
194,419 | 158,326 | 70,292 | |
133 |
194,419 | 158,326 | 70,292 | |
17/49 |
47,608 | 36,684 | 27,776 | |
42/48 |
47,608 | 36,684 | 27,776 | |
44 |
710 | 50 | - | |
440/4 |
710 | 50 | - | |
45 |
46,898 | 36,634 | 27,776 | |
450/3 |
46,898 | 36,634 | 27,776 | |
| Income statement | ||||
9900 |
42,182 | 121,451 | 97,071 | |
630 |
2,107 | 1,667 | 620 | |
9901 |
40,075 | 119,784 | 96,451 | |
75/76B |
6,351 | 4,883 | 1,618 | |
75 |
6,351 | 4,883 | 1,618 | |
65/66B |
69 | 0 | - | |
65 |
69 | 0 | - | |
9903 |
46,356 | 124,667 | 98,068 | |
67/77 |
10,264 | 36,634 | 27,776 | |
9904 |
36,092 | 88,034 | 70,292 | |
9905 |
36,092 | 88,034 | 70,292 | |
| Appropriation of the result | ||||
9906 |
36,092 | 88,034 | 70,292 | |
691/2 |
36,092 | 88,034 | 70,292 | |
6921 |
36,092 | 88,034 | 70,292 | |
| Document | ||||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 25-08-2026.
2025 annual accounts filed 25 days after the deadline. Filed on 25 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00431042.
| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 42,182 | 121,451 | 97,071 | ||
| 38,199 | 89,700 | 70,913 | ||
| 1,434 | 0 | 5,000 | ||
| 16,552 | 61,902 | - | ||
| 197,378 | 160,613 | 70,913 | ||
| 80.7% | 81.7% | 73.1% | ||
| 5.15 | 5.38 | 3.55 | ||
| 0.24 | 0.22 | 0.37 | ||
| 18.1% | 53.9% | 93.4% | ||
| 14.6% | 44.0% | 68.2% | ||
| over 100 | over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | €1,434 | - | €5,000 |
| €2,107 | €1,667 | €620 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is 67% lower than in 2024 and the lowest since 2023.
Debt's share of the balance-sheet total rises from 18.3% to 19.3%. Equity and debt are higher.
ISCARE has no parent and no holdings in its annual accounts. is the only director. ISCARE shares no director with another company.
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
| Establishment | Since | Unit number |
|---|---|---|
| Groeselenbergstraat 57D12 registered office 1180 Uccle 86220 Specialist medical practice | 17-08-2023 | 2.349.587.250 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21612D0042/00R000 | 834 m² | 1 · 249 m² | 14.3 m · 2 |
If something looks wrong or is missing, please tell us.